MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

Phase 1
Completed
Conditions
Tuberculosis
Interventions
Biological: Intradermal MVA85A
Biological: Aerosol inhaled MVA85A
First Posted Date
2011-12-22
Last Posted Date
2013-07-02
Lead Sponsor
University of Oxford
Target Recruit Count
24
Registration Number
NCT01497769
Locations
🇬🇧

Centre of Clinical Vaccinology and Tropical Medicine (CCVTM) Churchill Hospital, Oxford, United Kingdom

What is the Impact of Early Life Exposures on the Cardiovascular System in Young Adulthood?

Completed
Conditions
Preterm Birth
First Posted Date
2011-12-07
Last Posted Date
2019-01-08
Lead Sponsor
University of Oxford
Target Recruit Count
234
Registration Number
NCT01487824
Locations
🇬🇧

Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

Phase 1
Completed
Conditions
Influenza
Interventions
Biological: TIV and MVA-NP+M1
Biological: Saline placebo and seasonal influenza vaccine TIV
First Posted Date
2011-11-04
Last Posted Date
2012-11-29
Lead Sponsor
University of Oxford
Target Recruit Count
24
Registration Number
NCT01465035
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe

Not Applicable
Completed
Conditions
Malaria
Plasmodium Falciparum
Interventions
Biological: Plasmodium falciparum sporozoites 2sites
Biological: Plasmodium falciparum sporozoites 1 site
Biological: Plasmodium falciparum sporozoites 1site
First Posted Date
2011-11-04
Last Posted Date
2013-06-24
Lead Sponsor
University of Oxford
Target Recruit Count
18
Registration Number
NCT01465048
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Gene Therapy for Blindness Caused by Choroideremia

Phase 1
Completed
Conditions
Choroideremia
Interventions
Drug: rAAV2.REP1
First Posted Date
2011-10-28
Last Posted Date
2017-11-17
Lead Sponsor
University of Oxford
Target Recruit Count
14
Registration Number
NCT01461213
Locations
🇬🇧

St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

🇬🇧

Oxford Radcliffe Hospitals NHS Trust, Oxford, United Kingdom

🇬🇧

Eye Unit, Southampton University Hospitals NHS Trust, Southampton, United Kingdom

and more 1 locations

Understanding Immunity Persistence After Adolescent MenC Vaccination

Completed
Conditions
Antibody Persistance After Booster Dose of Men C Vaccine
Interventions
Other: Venepuncture and blood sample collection.
First Posted Date
2011-10-25
Last Posted Date
2015-11-09
Lead Sponsor
University of Oxford
Target Recruit Count
134
Registration Number
NCT01459432
Locations
🇬🇧

Oxford Vaccine Group, Oxford, United Kingdom

Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS

Phase 1
Completed
Conditions
Malaria
Interventions
Biological: ChAd63 CS
Biological: ChAd63, MVA CS
Biological: ChAd63 CS, MVA CS
First Posted Date
2011-10-12
Last Posted Date
2012-11-29
Lead Sponsor
University of Oxford
Target Recruit Count
24
Registration Number
NCT01450280
Locations
🇮🇪

Clinical Research Centre Royal College of Surgeons in Ireland (RCSI), Beaumont Hospital, Dublin, Ireland

AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area

Phase 1
Completed
Conditions
Malaria
Interventions
Biological: AdCH63 ME-TRAP, MVA ME-TRAP
First Posted Date
2011-10-12
Last Posted Date
2013-12-12
Lead Sponsor
University of Oxford
Target Recruit Count
72
Registration Number
NCT01450293
Locations
🇬🇲

Medical Research Council Laboratories, Banjul, Gambia

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

Phase 4
Completed
Conditions
Metabolic Disease
Interventions
First Posted Date
2011-09-30
Last Posted Date
2018-06-27
Lead Sponsor
University of Oxford
Target Recruit Count
1
Registration Number
NCT01443806
Locations
🇹🇭

The Faculty of Tropical medicine,Mahidol University, Bangkok, Thailand

OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression

Phase 2
Completed
Conditions
Depression
Interventions
Other: OxIGen
First Posted Date
2011-09-29
Last Posted Date
2014-01-09
Lead Sponsor
University of Oxford
Target Recruit Count
150
Registration Number
NCT01443234
Locations
🇬🇧

Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

🇬🇧

MRC Cognition and Brain Sciences Unit, Cambridge, Cambridgeshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath